Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

255.00
+4.091.63%
Post-market: 255.810.8100+0.32%19:57 EDT
Volume:4.40M
Turnover:1.12B
Market Cap:450.68B
PE:72.04
High:255.31
Open:251.23
Low:249.74
Close:250.91
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.03
T/O Rate:0.25%
Dividend:6.83
Dividend Rate:2.68%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-75.94
PE(LYR):108.05

Loading ...

AbbVie Publishes Pipeline Presentation Highlighting July 2026 R&D Program Updates

Reuters
·
Jul 31

AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat

Benzinga Earnings
·
Jul 31

Movement Alert|AbbVie Falls 3.04% in Regular Trading, Q2 Beat Overshadowed by Full-Year EPS Guidance Cut on Acquisition Dilution

Market Focus
·
Jul 31

AbbVie says ‘quite pleased’ with Skyrizi momentum

TIPRANKS
·
Jul 31

AbbVie Has 2Q Beat Helped by Skyrizi and Rinvoq

Dow Jones
·
Jul 31

Abbvie Shares Down 2.2% After Co Trims 2026 Profit Forecast

THOMSON REUTERS
·
Jul 31

Abbvie Exec Says NOW Expect Total Annual Net Revenue of Approximately $67.6 Billion, Increase of $300 Million Versus Previous Forecast - Conf Call

THOMSON REUTERS
·
Jul 31

Abbvie Exec Says in Third Quarter it Expects Adjusted Profit Per Share Between $3.84 and $3.88 - Conf Call

THOMSON REUTERS
·
Jul 31

AbbVie Bought Apogee to Strengthen Its Portfolio. Now It's Cutting Earnings Guidance.

Dow Jones
·
Jul 31

AbbVie Lowers Outlook to Account for Acquisition, as 2Q Profit Jumps

Dow Jones
·
Jul 31

AbbVie Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Jul 31

AbbVie Falls After Trimming 2026 Profit Forecast

Reuters
·
Jul 31

AbbVie Beats Q2 Revenue, Adjusted EPS Estimates but Cuts FY Adj EPS Guidance

Reuters
·
Jul 31

Movement Alert|AbbVie Falls 4.29% in Pre-Market Trading, Q2 Earnings Beat Expectations but Acquisition Dilution Weighs on Full-Year Guidance

Market Focus
·
Jul 31

AbbVie Q2 2026 earnings: Immunology and neuroscience drive 10.2% revenue growth

TradingKey
·
Jul 31

Abbvie Shares Down 3.6% Premarket After Co Cuts 2026 Profit Forecast on Apogee Buy

THOMSON REUTERS
·
Jul 31

GUIDANCE: (ABBV) AbbVie Expects 2026 Adjusted EPS Range $13.87 - $14.07, vs. FactSet Est of $14.06

MT Newswires Live
·
Jul 31

AbbVie Q2 Adj. EPS $3.65 Beats $3.60 Estimate, Sales $16.990B Beat $16.765B Estimate

Benzinga Earnings
·
Jul 31

AbbVie Trims 2026 Profit Forecast on Apogee Buy, Beats Second-quarter Estimates

Reuters
·
Jul 31

AbbVie Q2 GAAP EPS Climbs 290.4% to $2.03; Net Revenues Rise 10.2% to $16.99 Billion vs Q2 FY25

Reuters
·
Jul 31